It's FDA-approved for type 2 diabetes and has shown potentially greater weight loss effects than traditional GLP-1 medications in clinical trials
This article Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval originally appeared on Benzinga.com 2024 Benzinga.com
Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors
Puzzled, they turned to a colleague, Thue Schwartz, who had recently returned to Copenhagen from a postdoc with Donald Steiner at the University of Chicago, where he learned the same types of peptide-synthesis techniques Mojsov excelled in
AI chat is available 24/7 on the main site, but email at [email protected] is essentially nonfunctional in my experience
a mean increase of 6.9% among participants switched to placebo, for a difference of 14.8 percentage points (95% CI, 16 to 13.5)